Related Experiment Video
Updated: Jul 8, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
PSA spike after brachytherapy For localized prostate cancer
Laurie Abel1, Debra Zeroski, Sarah Brammer
1Schiffler Cancer Center, Wheeling, WV, USA.
Urologic Nursing
|January 26, 2008
Summary
Following prostate cancer treatment, a rise in prostate-specific antigen (PSA) levels is common and often not a cause for alarm. Healthcare professionals can help patients and families understand these benign PSA spikes.
Area of Science:
- Oncology
- Urology
- Medical Diagnostics
Background:
- Elevated prostate-specific antigen (PSA) levels after definitive prostate cancer treatment are a frequent patient concern.
- Understanding the causes of post-treatment PSA spikes is crucial for patient management.
Purpose of the Study:
- To address patient and family anxiety regarding post-treatment PSA level elevations.
- To elucidate the potential benign causes of PSA spikes following prostate cancer therapy.
Main Methods:
- Review of clinical data and common etiological factors for PSA fluctuations.
- Assessment of diagnostic criteria for benign PSA elevations.
Main Results:
- Post-treatment PSA spikes can arise from various factors, many of which are benign.
- Clinical assessment by healthcare workers can differentiate benign from concerning PSA trends.
Conclusions:
- Informed assessment by healthcare professionals can alleviate patient and family fears related to PSA spikes.
- Understanding the benign nature of many PSA elevations is key to supportive post-treatment care.
